Key result
A 57-year-old male presented with a rare, unresectable ewingoid dedifferentiated liposarcoma of the spermatic cord featuring a unique 22/22q trisomy that progressed despite doxorubicin therapy.
Why the study?
Liposarcomas of the spermatic cord are rare and often misdiagnosed clinically and histologically, leading to ineffective management and poor outcomes.
Case Report (n=1)
Accurate diagnosis of spermatic cord tumors is essential to prevent recurrence and severe local complications such as vascular and urethral compression.
Rare spermatic cord sarcomas warrant genetic profiling; case reports leave open targeted options beyond doxorubicin.
Liposarcomas of the spermatic cord are rare and often clinically and histologically misdiagnosed, leading to ineffective management and poor outcomes. We present a case of metastatic dedifferentiated liposarcoma of the spermatic cord, which recurred after excision of a misdiagnosed well-differentiated liposarcoma 3 years prior. Due to its size and high-grade metastasis, the tumor was unresectable, leading to treatment with systemic chemotherapy. Complications arose including partial compression of the testicular artery and urethral obstruction secondary to local mass effect. Tumor biopsy was characterized by a unique immunohistochemical profile which helped to explain the unique processes leading to mass effect, vascular and urethral compression, and bilateral scrotal swelling. The patient’s family history of malignancy and 22/22q trisomy identified in the tumor biopsy were also interesting contributors. In conclusion, accurate diagnosis of spermatic cord tumors is essential for effective treatment, and further data collection is required to improve management of advanced metastatic disease.
No takes yet. Share an insight, caveat, or question.
Dalton et al. (2022) conducted a case report in Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord (n=1). Doxorubicin was evaluated. A 57-year-old male presented with a rare, unresectable ewingoid dedifferentiated liposarcoma of the spermatic cord featuring a unique 22/22q trisomy that progressed despite doxorubicin therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: